We are testing whether exercise training during chemotherapy is helpful in protecting heart function and maintaining exercise capacity.
The chemotherapy medications used for breast cancer are important for achieving a cure but a potential side effect is that they can effect heart function.
We are conducting a study which aims to identify heart muscle damage at the earliest possible stage using exercise testing and state-of-the-art MRI imaging of the heart.
Furthermore, we are testing whether exercise training during chemotherapy is helpful in protecting heart function and maintaining exercise capacity.
Who can participate?
Participants must be:
- aged 18–70 years
- diagnosed with breast cancer
- scheduled for Anthracycline-based chemotherapy
- capable of walking up 2 flights of stairs.
What is involved?
This study involves testing (2 exercise tests and 1 heart ultrasound test ('echocardiography') before and after chemotherapy treatment. All test will be performed at the Baker Specialist Clinics in Melbourne.
If you are interested in participating or would like further information, please contact:
T: +61 3 8532 1169